Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1999-03-01
2000-05-02
Clardy, S. Mark
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514172, 514176, 514182, 514826, 514958, A61K 3156, A61K 3158
Patent
active
060573074
ABSTRACT:
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
REFERENCES:
patent: 4472393 (1984-09-01), Shapiro
PR Newswire, Nov. 30, 1988, 4 pages.
H. J. Lee et al., "Anti-Inflammatory Steroids: Research Trends and New Compounds," Drugs of Today, vol. 25, pp. 577-588, 1989.
Business Wire, Nov. 14, 1990, 5 pages.
Predicasts Marketletter, Mar. 30, 1992, 3 pages.
I. M. Richards et al., "Novel Steroid-Based Inhibitors of Lung Inflammation," Clinical and Experimental Allergy, vol. 22, pp. 432-439, 1992.
C. J. Wang et al., "A Sensitive Enzyme Immunoassay (EIA) for Quantitation of Mometasone Furoate (SCH 32088) Directly in Biological Fluids," Abstract 2119, FASEB J., vol. 6, No. 4, p. A1302, 1992.
C-J. Wang et al., "A Competitive Enzyme Immunoassay for the Direct Determination of Mometasone Furoate (SCH 32088) in Human Plasma," Journal of Pharmaceutical and Biomedical Analysis, vol. 10, pp. 473-479, 1992.
D. Debrovner, "Why Asthmatics Need You," American Druggist, pp. 24-27, Aug. 1994.
M. Drouin et al., "Once Daily Mometasone Furoate Aqueous Nasal Spray is as Effective as Twice Daily Beclomethasone Dipropionate for Treating Perennial Allergic Rhinitis Patients," Annals of Allergy, Asthma & Immunology, vol. 77, pp. 153-160, 1996.
Cayen Mitchell
Chaudry Imtiaz A.
Cuss Francis M.
Nagabhushan Nagamani
Nolop Keith B.
Clardy S. Mark
Franks Robert A.
Hoffman Thomas D.
Schering Corporation
LandOfFree
Use of mometasone furoate for treating airway passage and lung d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of mometasone furoate for treating airway passage and lung d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mometasone furoate for treating airway passage and lung d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1593934